U.S. FDA Approves PADCEV plus Keytruda for Certain Patients with Bladder Cancer
Pfizer Inc. and Astellas Pharma Inc., led by President and CEO Naoki Okamura, announced that the U.S. Food and Drug Administration has approved PADCEV (enfortumab vedotin-ejfv) in combination with...
